Chloride channel myotonia: exon 8 hot-spot for dominant-negative interactions

被引:88
作者
Fialho, D.
Schorge, S.
Pucovska, U.
Davies, N. P.
Labrum, R.
Haworth, A.
Stanley, E.
Sud, R.
Wakeling, W.
Davis, M. B.
Kullmann, D. M.
Hanna, M. G.
机构
[1] UCL, MRC Ctr Neuromuscular Dis, Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England
[2] UCL, Natl Hosp Neurol, Dept Clin & Expt Epilepsy, London, England
[3] Univ Birmingham, Queen Elizabeth Hosp, NHS Trust, Muscle & Nerve Ctr,Dept Neurol, Birmingham B15 2TH, W Midlands, England
基金
英国惠康基金; 英国医学研究理事会;
关键词
myotonia congenita; channelopathy; chloride channel; CLCN1;
D O I
10.1093/brain/awm248
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Myotonia congenita (MC) is the commonest genetic skeletal muscle ion channelopathy. It is caused by mutations in CLCN1 on chromosome 7q35, which alter the function of the major skeletal muscle voltage-gated chloride channel. Dominant and recessive forms of the disease exist. We have undertaken a clinical, genetic and molecular expression study based upon a large cohort of over 300 UK patients. In an initial cohort of 22 families, we sequenced the DNA of the entire coding region of CLCN1 and identified 11 novel and 11 known mutations allowing us to undertake a detailed genotypephenotype correlation study. Generalized muscle hypertrophy, transient weakness and depressed tendon reflexes occurred more frequently in recessive than dominant MC. Mild cold exacerbation and significant muscle pain were equally common features in dominant and recessive cases. Dominant MC occurred in eight families. We noted that four newly identified dominant mutations clustered in exon 8, which codes for a highly conserved region of predicted interaction between the CLC-1 monomers. Expressed in Xenopus oocytes these mutations showed clear evidence of a dominant-negative effect. Based upon the analysis of mutations in this initial cohort as well as a review of published CLCN1 mutations, we devised an exon hierarchy analysis strategy for genetic screening. We applied this strategy to a second cohort of 303 UK cases with a suspected diagnosis of MC. In 23 individuals, we found two mutations and in 86 individuals we identified a single mutation. Interestingly, 40 of the cases with a single mutation had dominant exon 8 mutations. In total 48 individuals (from 34 families) in cohort 1 and 2 were found to harbour dominant mutations (37 of mutation positive individuals, 30 of mutation positive families). In total, we have identified 23 new disease causing mutations in MC, confirming the high degree of genetic heterogeneity associated with this disease. The DNA-based strategy we have devised achieved a genetic diagnosis in 36 of individuals referred to our centre. Based on these results, we propose that exon 8 of CLCN1 is a hot-spot for dominant mutations. Our molecular expression studies of the new exon 8 mutations indicate that this region of the chloride channel has an important role in dominant negative interactions between the two chloride channel monomers. Accurate genetic counselling in MC should be based not only upon clinical features and the inheritance pattern but also on molecular genetic analysis and ideally functional expression data.
引用
收藏
页码:3265 / 3274
页数:10
相关论文
共 21 条
[1]  
Becker PE, 1977, MYOTONIA CONGENITA S
[2]   Phenotypic variability in myotonia congenita [J].
Colding-Jorgensen, E .
MUSCLE & NERVE, 2005, 32 (01) :19-34
[3]   Decrement of compound muscle action potential is related to mutation type in myotonia congenita [J].
Colding-Jorgensen, E ;
Duno, M ;
Schwartz, M ;
Vissing, J .
MUSCLE & NERVE, 2003, 27 (04) :449-455
[4]   The skeletal muscle channelopathies: basic science, clinical genetics and treatment [J].
Davies, NP ;
Hanna, MG .
CURRENT OPINION IN NEUROLOGY, 2001, 14 (05) :539-551
[5]   Involvement of helices at the dimer interface in C1C-1 common gating [J].
Duffield, M ;
Rychkov, G ;
Bretag, A ;
Roberts, M .
JOURNAL OF GENERAL PHYSIOLOGY, 2003, 121 (02) :149-161
[6]   X-ray structure of a CIC chloride channel at 3.0 Å reveals the molecular basis of anion selectivity [J].
Dutzler, R ;
Campbell, EB ;
Cadene, M ;
Chait, BT ;
MacKinnon, R .
NATURE, 2002, 415 (6869) :287-294
[7]  
GEORGE AL, 1994, HUM MOL GENET, V3, P2071
[8]   MOLECULAR-BASIS OF THOMSEN DISEASE (AUTOSOMAL DOMINANT MYOTONIA-CONGENITA) [J].
GEORGE, AL ;
CRACKOWER, MA ;
ABDALLA, JA ;
HUDSON, AJ ;
EBERS, GC .
NATURE GENETICS, 1993, 3 (04) :305-310
[9]   THE SKELETAL-MUSCLE CHLORIDE CHANNEL IN DOMINANT AND RECESSIVE HUMAN MYOTONIA [J].
KOCH, MC ;
STEINMEYER, K ;
LORENZ, C ;
RICKER, K ;
WOLF, F ;
OTTO, M ;
ZOLL, B ;
LEHMANNHORN, F ;
GRZESCHIK, KH ;
JENTSCH, TJ .
SCIENCE, 1992, 257 (5071) :797-800
[10]   ClC-1 chloride channel mutations in myotonia congenita: variable penetrance of mutations shifting the voltage dependence [J].
Kubisch, C ;
Schmidt-Rose, T ;
Fontaine, B ;
Bretag, AH ;
Jentsch, TJ .
HUMAN MOLECULAR GENETICS, 1998, 7 (11) :1753-1760